Health ❯Medicine ❯Pharmaceuticals

Clinical Trials

Weight Loss Treatments Donanemab vs Leqembi Drug Development Patient Data Analysis Breakthrough Therapy Weight Loss Drugs Efficacy Studies Weight Reduction Obesity Medication Semaglutide Trial Zepbound Clinical Trials Phase 3 Studies Treatment Development

FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes Patients

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

Amgen's Weight-Loss Drug Shows Promise but Faces Investor Skepticism

Boehringer Ingelheim's Survodutide Wins FDA Breakthrough Status for MASH Treatment

Novo Nordisk's Amycretin Pill Shows Promising Weight Loss Results in Early Trial

Ozempic Linked to Lower Dementia Risk and Reduced Nicotine Dependence

Akira Endo, Pioneer of Cholesterol-Lowering Statins, Passes Away at 90

Altimmune's Weight Loss Drug Shows Promising Results in Minimizing Muscle Loss

Viking Therapeutics' New Weight Loss Drug Shows Promising Trial Results

Eli Lilly's Weight-Loss Drug Zepbound Now Available in U.S. Pharmacies